Revenue - Gensight Biologics SA (PAR:SIGHT) - Alpha Spread

Gensight Biologics SA
PAR:SIGHT

Watchlist Manager
Gensight Biologics SA Logo
Gensight Biologics SA
PAR:SIGHT
Watchlist
Price: 0.38 EUR -3.8%
Market Cap: 39.3m EUR
Have any thoughts about
Gensight Biologics SA?
Write Note

Gensight Biologics SA
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Gensight Biologics SA
Revenue Peer Comparison

Comparables:
VLA
NANO
IPH
GNFT
ALERS

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Gensight Biologics SA
PAR:SIGHT
Revenue
€1.3m
CAGR 3-Years
-34%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Revenue
€221.6m
CAGR 3-Years
26%
CAGR 5-Years
15%
CAGR 10-Years
20%
Nanobiotix SA
PAR:NANO
Revenue
€30.1m
CAGR 3-Years
744%
CAGR 5-Years
204%
CAGR 10-Years
67%
Innate Pharma SA
PAR:IPH
Revenue
€24.9m
CAGR 3-Years
-10%
CAGR 5-Years
-26%
CAGR 10-Years
11%
Genfit SA
NASDAQ:GNFT
Revenue
€38.2m
CAGR 3-Years
70%
CAGR 5-Years
38%
CAGR 10-Years
20%
Eurobio Scientific SA
PAR:ALERS
Revenue
€130m
CAGR 3-Years
-12%
CAGR 5-Years
21%
CAGR 10-Years
16%

See Also

What is Gensight Biologics SA's Revenue?
Revenue
1.3m EUR

Based on the financial report for Dec 31, 2023, Gensight Biologics SA's Revenue amounts to 1.3m EUR.

What is Gensight Biologics SA's Revenue growth rate?
Revenue CAGR 3Y
-34%

Over the last year, the Revenue growth was -51%. The average annual Revenue growth rates for Gensight Biologics SA have been -34% over the past three years .

Back to Top